Facebook
Twitter
LinkedIn
ForwardColorectal Cancer Screening: A Provider's Guide to Improve Screening Focusing on Medically Vulnerable Populations
Colorectal cancer screening rates are low within low SES and among African-American, Latino and in several Asian-American groups, in part due to lack of awareness, fewer provider recommendations, lack of access to care, and underutilization of Stool-based tests by providers.
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in California. African-Americans have 20% greater risk and 40% higher death due to CRC than general population. Incidence rate in most subgroups has decreased; however, it has increased among younger persons and Korean-Americans. Despite lifesaving CRC screening, African-American, Latino and in several Asian-American groups (Pacific-Islanders, Korean, Chinese), CRC screening is abysmally low. Antelope (AV-SPA1) and San Gabriel Valley (SGV-SPA3) fare worse than other SPAs in Los Angeles County. In AV-SPA1 and SGV-SPA3, 51.5% of eligible adults are in compliance with CRC screening compared to 56.3% in Los Angeles County and national rates (68.8%).
Target Audience
All healthcare providers and clinical staff.
Learning Objectives
- Identify colorectal cancer (CRC) disparities in vulnerable populations.
- Outline current CRC screening guidelines.
- Discuss consistency of stool-based screening test distribution.
- Discuss strategies to overcome barriers to screening and follow-up completion.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Virtual Meeting- Zoom
Gregory Idos, MD, MS Associate Professor of Clinical Medicine, Department of Medicine, Division of Gastroenterology, Division of Clinical Cancer Genomics; City of Hope National Medical Center
Trilokesh Kidambi, MD Assistant Clinical Professor; Director, Colon Cancer Screening Program; City of Hope National Medical Center
Dr. Idos and Dr. Kidambi have both indicated they have nothing to disclose.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1™ 1.5
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.5 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Available Credit
- 1.50 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this Colorectal Cancer Screening: A Provider's Guide to Improve Screening Focusing on Medically Vulnerable Populations for a maximum of 1.50 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.50 Attendance